Sodium-glucose cotransporter 2 inhibitors in the context of cardiorenal-metabolic comorbidity. Part 1 : Pathophysiology and key clinical studies (pealkiri)

teaviku laadid

Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Toon andmeid..
Kirjeid leitud 1, kuvan 1 - 1